Home » Gilead Stops Leukemia Drug Trial Early on Patient Benefit
Gilead Stops Leukemia Drug Trial Early on Patient Benefit
Gilead is planning to stop a trial of its leukemia drug idelalisib early because the drugmaker has seen positive results in patients taking the drug.
Bloomberg
Bloomberg
Upcoming Events
-
07May
-
14May
-
30May